Journal articleHepatobiliary Pancreat Dis Int2023
Targeting mitochondrial transcription factor A sensitizes pancreatic cancer cell to gemcitabine.
- Journal
- Hepatobiliary Pancreat Dis Int
- Published
- 21 March 2023
- Citations
- 5
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background The survival of pancreatic cancer cells, particularly cancer stem cells which are responsible for tumor relapse, depends on mitochondrial function. Mitochondrial transcription factor A (TFAM) is critical for the regulation of mitochondrial DNA and thus mitochondrial function. … Excerpt only: this text is the publisher’s. Read it in full at the source.